Remove Congenital Heart Disease Remove Pediatrics Remove Pulmonary
article thumbnail

Medtronic Receives CE Mark for Transcatheter Pulmonary Valve Replacement System

DAIC

6, 2025 Medtronic plc hasannounced it received CE ( Conformit Europenne ) Mark for the Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT).

article thumbnail

Case Report: A new therapeutic option for a rare patent ductus arteriosus child complicated with pulmonary artery aneurysm due to infectious endocarditis

Frontiers in Cardiovascular Medicine

Patent ductus arteriosus (PDA) is one of the most common forms of congenital heart disease (CHD). PDA combined with pulmonary artery aneurysm (PAA) due to IE is rare in children. In this report, we report a rare pediatric PDA case, complicated with PAA due to IE.

article thumbnail

Cardiopulmonary Exercise Test Interpretation Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association

Journal of the American Heart Association

Journal of the American Heart Association, Ahead of Print. Survivorship from congenital heart disease has improved rapidly secondary to advances in surgical and medical management. This is an updated report of the American Heart Association's previous publications on exercise in children.

article thumbnail

Hot Topics in Congenital and Pediatric Cardiology in the Year 2023

American College of Cardiology

This year saw exciting developments in the treatment of pediatric and congenital heart disease. Transcatheter pulmonary valve replacement (TPVR) continued to dominate the field of interventional cardiology.

article thumbnail

Application of a modified clinical classification for pulmonary arterial hypertension associated with congenital heart disease in children: emphasis on atrial septal defects and transposition of the great arteries. An analysis from the TOPP registry

Frontiers in Cardiovascular Medicine

Aims A proportion of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) do not fit in the current classification. The role of ASD in pediatric PH should be reconsidered. No survival difference could be demonstrated between the groups.

article thumbnail

Absorbable metal stents for vascular use in pediatric cardiology: progress and outlook

Frontiers in Cardiovascular Medicine

Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD). We also discuss the challenges and our center's experience associated with the use of absorbable metal stents in this pediatric population.

Stents 52
article thumbnail

Ebstein’s Anomaly of Tricuspid Valve

All About Cardiovascular System and Disorders

Transcript of the video: Ebstein’s Anomaly is one of the cyanotic congenital heart disease in which survival to adult life is common. The cyanosis in Ebstein’s anomaly, is usually not due to pulmonary hypertension, but because tricuspid regurgitation jet is directed across the atrial septal defect.